Cargando…
Vogt-Koyanagi-Harada Disease Exacerbation Associated with COVID-19 Vaccine
We describe a case of Vogt-Koyanagi-Harada (VKH) disease exacerbation after COVID-19 vaccination. A 46-year-old woman presented with a bilateral granulomatous uveitis 2 days after the first dose of COVID-19 mRNA vaccine (Comirnaty, Pfizer-BioNTech), and was diagnosed with a complete Vogt-Koyanagi-Ha...
Autores principales: | De Domingo, Begoña, López, Miguel, Lopez-Valladares, Maria, Ortegon-Aguilar, Esperanza, Sopeña-Perez-Argüelles, Bernardo, Gonzalez, Francisco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8947156/ https://www.ncbi.nlm.nih.gov/pubmed/35326462 http://dx.doi.org/10.3390/cells11061012 |
Ejemplares similares
-
Vogt-Koyanagi-Harada Disease and COVID
por: Manni, Priscilla, et al.
Publicado: (2023) -
Treatment of Vogt-Koyanagi-Harada Disease
por: Alaql, Musab K, et al.
Publicado: (2020) -
Tofacitinib in Vogt-Koyanagi-Harada disease
por: Dutta Majumder, Parthopratim, et al.
Publicado: (2020) -
An Unusual Presentation of Vogt–Koyanagi–Harada
por: Ipek, Sefik Can, et al.
Publicado: (2021) -
A COVID-19 perspective of Vogt–Koyanagi–Harada disease
por: Dutta Majumder, Parthopratim, et al.
Publicado: (2023)